KENNETH VETTEL: Open Payments
NPI 1740233873 · GRAND ISLAND, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$148 in 8 payments from 6 companies in 2025. Trend: 2023 $180 · 2024 $181 · 2025 $148
Food & beverage: $148
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $48 |
| Novo Nordisk Inc | 2 | $35 |
| Optinose US, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $5 |
Products named: FREESTYLE LIBRE 3, Xhance, CAPLYTA, Ozempic, Rybelsus, XIFAXAN, VOQUEZNA.
Industry payments across NE — which companies pay providers there.
